100% Quality Guarantee
PhD-Level Technical Support
Western blot analysis of Human coronavirus (HCoV-229E) Spike Protein (S1+S2 ECD His Tag), using HCoV-229E Spike S2 antibody (CAB22604) at 1:70000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25μg per lane. Blocking buffer: 3% nonfat dry milk in TBST.
Key Features

HCoV-229E Spike S2 Monoclonal Antibody (CAB22604)

SKU CAB22604
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity HCoV-229E
Host Species Rabbit
€131 - €457

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

HCoV-229E Spike S2 Monoclonal Antibody (CAB22604)

The HCoV-229E Spike S2 Monoclonal Antibody (CAB22604) is a high-quality antibody developed for reliable detection and analysis of target proteins. This antibody, produced through monoclonal techniques, is highly specific and reactive with human samples, making it an ideal tool for studying the mechanisms of infection and immune response against this coronavirus strain.The Spike S2 protein of HCoV-229E is a critical component involved in viral entry into host cells and plays a key role in the infectivity and pathogenesis of the virus. By targeting this protein with the monoclonal antibody, researchers can elucidate the molecular interactions between the virus and host cells, paving the way for the development of novel therapeutics and vaccines against HCoV-229E.

This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against HCoV-229E samples.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose